| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Bioinformatics and Computational Biology, School of Computational Sciences, George Mason University, 10900 University Boulevard, MSN 5B3, Manassas, VA 20110, USA
2 Division of Microbiology, Department of Infectious and Parasitic Diseases Pathology, Armed Forces Institute of Pathology, 5300 Georgia Avenue NW, Washington, DC 20306, USA
3 Department of Virology, American Type Culture Collection (ATCC), Manassas, VA 20108, USA
4 HQ USAF Surgeon General Office, Directorate of Modernization (SGR), 5201 Leesburg Pike, Suite 1401, Falls Church, VA 22041, USA
5 Epidemic Outbreak Surveillance (EOS) Consortium, 5201 Leesburg Pike, Suite 1401, Falls Church, VA 22041, USA
Correspondence
Donald Seto
dseto{at}gmu.edu
The 36 001 base pair DNA sequence of human adenovirus serotype 1 (HAdV-1) has been determined, using a ‘leveraged primer sequencing strategy’ to generate high quality sequences economically. This annotated genome (GenBank AF534906) confirms anticipated similarity to closely related species C (formerly subgroup), human adenoviruses HAdV-2 and -5, and near identity with earlier reports of sequences representing parts of the HAdV-1 genome. A first round of HAdV-1 sequence data acquisition used PCR amplification and sequencing primers from sequences common to the genomes of HAdV-2 and -5. The subsequent rounds of sequencing used primers derived from the newly generated data. Corroborative re-sequencing with primers selected from this HAdV-1 dataset generated sparsely tiled arrays of high quality sequencing ladders spanning both complementary strands of the HAdV-1 genome. These strategies allow for rapid and accurate low-pass sequencing of genomes. Such rapid genome determinations facilitate the development of specific probes for differentiation of family, serotype, subtype and strain (e.g. pathogen genome signatures). These will be used to monitor epidemic outbreaks of acute respiratory disease in a defined test bed by the Epidemic Outbreak Surveillance (EOS) project.
This article has been cited by other articles:
|
|
 |
|
  A. N. Lukashev, O. E. Ivanova, T. P. Eremeeva, and R. D. Iggo Evidence of frequent recombination among human adenoviruses J. Gen. Virol., February 1, 2008; 89(2): 380 - 388. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. Jones II, B. Harrach, R. D. Ganac, M. M. A. Gozum, W. P. dela Cruz, B. Riedel, C. Pan, E. L. Delwart, and D. P. Schnurr New Adenovirus Species Found in a Patient Presenting with Gastroenteritis J. Virol., June 1, 2007; 81(11): 5978 - 5984. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. Zhang, X. Su, S. Gong, Q. Zeng, B. Zhu, Z. Wu, T. Peng, C. Zhang, and R. Zhou Comparative genomic analysis of two strains of human adenovirus type 3 isolated from children with acute respiratory infection in southern China J. Gen. Virol., June 1, 2006; 87(6): 1531 - 1541. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Purkayastha, J. Su, J. McGraw, S. E. Ditty, T. L. Hadfield, J. Seto, K. L. Russell, C. Tibbetts, and D. Seto Genomic and Bioinformatics Analyses of HAdV-4vac and HAdV-7vac, Two Human Adenovirus (HAdV) Strains That Constituted Original Prophylaxis against HAdV-Related Acute Respiratory Disease, a Reemerging Epidemic Disease J. Clin. Microbiol., July 1, 2005; 43(7): 3083 - 3094. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Purkayastha, S. E. Ditty, J. Su, J. McGraw, T. L. Hadfield, C. Tibbetts, and D. Seto Genomic and Bioinformatics Analysis of HAdV-4, a Human Adenovirus Causing Acute Respiratory Disease: Implications for Gene Therapy and Vaccine Vector Development J. Virol., February 15, 2005; 79(4): 2559 - 2572. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
